R

Renier J. Brentjens

Roswell Park Comprehensive Cancer Center

ORCID: 0000-0002-3364-5388

Publishes on CAR-T cell therapy research, Immune Cell Function and Interaction, Immunotherapy and Immune Responses. 412 papers and 35.6k citations.

PubIndex Score98Top 2%How it's scored

🌟#9 Current Senior Leader in CAR-T cell therapy research

412Publications

35.6kTotal Citations

#9in CAR-T cell therapy research

First publication: 1994First senior author: 2004

CAR-T cell therapy research Immune Cell Function and Interaction Immunotherapy and Immune Responses Virus-based gene therapy research Viral Infectious Diseases and Gene Expression in Insects

Top publicationsby citations

Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia

Marco L. Davila, Renier J. Brentjens, P. Maslak et al.|Science Translational Medicine|2014

Cited by 2.5k

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

Sarwish Rafiq, Renier J. Brentjens|Nature Reviews Clinical Oncology|2019

Cited by 1.4k

CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date

Jae H. Park, Renier J. Brentjens|Blood|2016

Cited by 398

Armored CAR T cells enhance antitumor efficacy and overcome the tumor microenvironment

Oladapo Yeku, Renier J. Brentjens|Scientific Reports|2017

Cited by 397

GPRC5D-Targeted CAR T Cells for Myeloma

Sham Mailankody, Eric L. Smith, Sean M. Devlin et al.|New England Journal of Medicine|2022

Cited by 383